phosphatidylcholines has been researched along with tamoxifen in 15 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (tamoxifen) | Trials (tamoxifen) | Recent Studies (post-2010) (tamoxifen) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 20,630 | 2,227 | 6,256 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 8 (53.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ramu, A; Ramu, N; Rosario, LM | 1 |
| Levy, BL; Monaco, ME; Richardson, SB | 1 |
| Ermilova, VD; Krasil'nikov, MA; Letiagin, VP; Shatskaia, VA | 1 |
| Crilly, KS; Kiss, Z | 1 |
| Kiss, Z | 1 |
| Kayyali, R; Marriott, C; Wiseman, H | 1 |
| Almeida, LM; Custódio, JB; Madeira, VM | 1 |
| Barinov, VV; Bassalyk, LS; Krasil'nikov, MA; Kuzmina, ZV; Letyagin, VP; Shatskaya, VA | 1 |
| Cabot, MC; Cao, H; Giuliano, AE; Han, TY; Jones, RC; Lavie, Y; Zhang, Z | 1 |
| Bhatia, A; Bhushan, S; Katare, OP; Singh, B | 1 |
| Ahmad, MZ; Debnath, M; Sarwa, KK; Suresh, PK | 1 |
| Bilge, D; Kazanci, N; Sahin, I; Severcan, F | 1 |
| Dora, CP; Jena, SK; Singh, C; Suresh, S | 1 |
| Goda, K; Kobayashi, A; Maekawa, K; Saito, K; Saito, Y; Sugai, S; Yamada, N | 1 |
| Aranda, FJ; Ortiz, A; Ortiz, J; Teruel, JA | 1 |
15 other study(ies) available for phosphatidylcholines and tamoxifen
| Article | Year |
|---|---|
Circumvention of multidrug-resistance in P388 cells is associated with a rise in the cellular content of phosphatidylcholine.
Topics: Animals; Cell Membrane; Cell Membrane Permeability; Choline; Digitonin; Dipyridamole; Drug Resistance; Fura-2; Ionomycin; Leukemia P388; Lipids; Phosphatidylcholines; Potassium Chloride; Tamoxifen; Tumor Cells, Cultured; Valinomycin; Verapamil | 1991 |
Synergism between vasopressin and phorbol esters in stimulation of insulin secretion and phosphatidylcholine metabolism in RIN insulinoma cells.
Topics: Adenoma, Islet Cell; Animals; Arginine Vasopressin; Cell Line; Drug Synergism; Insulinoma; Kinetics; Pancreatic Neoplasms; Phloretin; Phosphatidylcholines; Rats; Tamoxifen; Tetradecanoylphorbol Acetate | 1988 |
[Evaluation of the effectiveness of tamoxifen in malignant breast tumors: new approaches].
Topics: Autoradiography; Breast Neoplasms; Estradiol; Female; Humans; Phosphatidylcholines; Phosphatidylinositols; Phospholipids; Phosphorus Radioisotopes; Protein Kinase C; Tamoxifen; Tumor Cells, Cultured | 1995 |
Tamoxifen inhibits uptake and metabolism of ethanolamine and choline in multidrug-resistant, but not in drug-sensitive, MCF-7 human breast carcinoma cells.
Topics: Biological Transport; Choline; Drug Resistance, Multiple; Ethanolamine; Ethanolamines; Humans; In Vitro Techniques; Phosphatidylcholines; Phosphatidylethanolamines; Tamoxifen; Tumor Cells, Cultured | 1995 |
Tamoxifen stimulates phospholipase D activity by an estrogen receptor-independent mechanism.
Topics: 3T3 Cells; Animals; Breast Neoplasms; Female; Humans; Hydrolysis; Mice; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipase D; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured | 1994 |
Tamoxifen decreases drug efflux from liposomes: relevance to its ability to reverse multidrug resistance in cancer cells?
Topics: Antineoplastic Agents; Chloroquine; Cholesterol; Drug Resistance; Humans; Kinetics; Liposomes; Membrane Fluidity; Neoplasms; Phosphatidylcholines; Tamoxifen | 1994 |
The active metabolite hydroxytamoxifen of the anticancer drug tamoxifen induces structural changes in membranes.
Topics: Animals; Cholesterol; Dimyristoylphosphatidylcholine; Fluorescence Polarization; Lipid Bilayers; Liposomes; Luminescent Measurements; Membrane Lipids; Muscles; Phosphatidylcholines; Rabbits; Sarcoplasmic Reticulum; Structure-Activity Relationship; Tamoxifen; Thermodynamics | 1993 |
Regulation of phospholipid turnover by steroid hormones in endometrial carcinoma and breast cancer cells.
Topics: Adenocarcinoma; Breast Neoplasms; Endometrial Neoplasms; Epidermal Growth Factor; Estradiol; Female; Gonadal Steroid Hormones; Humans; Neoplasms, Hormone-Dependent; Phosphatidylcholines; Phosphatidylinositols; Phospholipids; Progesterone; Tamoxifen; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1993 |
Tamoxifen activates cellular phospholipase C and D and elicits protein kinase C translocation.
Topics: Antineoplastic Agents, Hormonal; Diglycerides; Down-Regulation; Enzyme Activation; Humans; Hydrolysis; Phosphatidic Acids; Phosphatidylcholines; Phospholipase D; Protein Kinase C; Signal Transduction; Tamoxifen; Type C Phospholipases | 1997 |
Tamoxifen-encapsulated vesicular systems: cytotoxicity evaluation in human epidermal keratinocyte cell line.
Topics: Administration, Cutaneous; Cell Line; Cell Proliferation; Cell Survival; Cholesterol; Drug Carriers; Hexoses; Humans; Inhibitory Concentration 50; Keratinocytes; Liposomes; Membrane Fluidity; Phosphatidylcholines; Psoriasis; Selective Estrogen Receptor Modulators; Surface-Active Agents; Tamoxifen | 2010 |
Tamoxifen citrate loaded ethosomes for transdermal drug delivery system: preparation and characterization.
Topics: Administration, Cutaneous; Antineoplastic Agents, Hormonal; Calorimetry, Differential Scanning; Drug Compounding; Estrogen Antagonists; Ethanol; Humans; In Vitro Techniques; Liposomes; Particle Size; Phosphatidylcholines; Skin; Skin Absorption; Surface Properties; Tamoxifen | 2013 |
Interactions of tamoxifen with distearoyl phosphatidylcholine multilamellar vesicles: FTIR and DSC studies.
Topics: Calorimetry, Differential Scanning; Cell Line, Tumor; Humans; Lipids; Liposomes; Membranes, Artificial; Neoplasms; Phosphatidylcholines; Spectroscopy, Fourier Transform Infrared; Tamoxifen; Temperature | 2014 |
Development of tamoxifen-phospholipid complex: novel approach for improving solubility and bioavailability.
Topics: Animals; Antineoplastic Agents, Hormonal; Area Under Curve; Biological Availability; Female; Phosphatidylcholines; Rats, Sprague-Dawley; Solubility; Tamoxifen | 2014 |
Arachidonic acid-containing phosphatidylcholine characterized by consolidated plasma and liver lipidomics as an early onset marker for tamoxifen-induced hepatic phospholipidosis.
Topics: Animals; Arachidonic Acid; Biomarkers; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Lipid Metabolism; Lipidoses; Liver; Male; Phosphatidylcholines; Rats, Sprague-Dawley; Tamoxifen | 2017 |
Dissimilar action of tamoxifen and 4-hydroxytamoxifen on phosphatidylcholine model membranes.
Topics: Phosphatidylcholines; Tamoxifen | 2021 |